Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-04-03
1995-03-28
Hill, Jr., Robert J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 21, 514925, 514926, 514927, 514928, 514970, 514777, 514778, A61K 3700, A61K 4700, A01N 2500
Patent
active
054017211
ABSTRACT:
This invention describes pharmaceutical compositions and methods of treating ulcerating diseases of the gastrointestinal tract in mammals with an acid-resistant fibroblast growth factor compositions. Also described is the use of acid-resistant fibroblast growth factor compositions in the treatment of various other fibroblast growth factor-responsive conditions.
REFERENCES:
patent: 4296100 (1981-10-01), Franco
patent: 4745098 (1988-05-01), Michaeli
Illustrated Stedman's Medical Dictionary, 24th ed., Williams & Wilkins, Baltimore 1982, p. 280.
The Merck Index, 9th ed., Merck & Co., Inc. Rahway, N.J., 1976, APP-1 A3.
Folkman Moses J.
Kato Koichi
Children's Medical Center
Conlin David G.
Davenport A. M.
Hill Jr. Robert J.
Resnick David S.
LandOfFree
Acid-resistant FGF composition for treating ulcerating diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acid-resistant FGF composition for treating ulcerating diseases , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acid-resistant FGF composition for treating ulcerating diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2250572